Skip to content

Visoluten

Also called A-11, retina peptide bioregulator

Retina-derived peptide fraction. Khavinson-school organ peptide extracts.

  • TypeBioregulator
  • FormOral
  • Researched forLongevity

Where to get Visoluten

BioLongevity Supplements
Oral
Code CAMERON

The only form sold. Research compound, not approved for human use.

Shop oral at BioLongevity Supplements

The short version

  • Why people research itRetinal ageing and visual function; the eye-specific bioregulator.
  • What the evidence isNo randomized human trials — a research compound with no commercial route to funding one, so the correlative and theoretical tiers are the evidence base rather than a consolation prize.
  • What to watchSudden vision loss or flashes.

How Visoluten works

The proposal is tissue specificity: a short peptide fraction taken from one organ acts preferentially on that same organ, binding regulatory DNA sequences and shifting protein synthesis toward a younger pattern.

Khavinson-school organ peptide extracts. The claim is tissue specificity: a short peptide fraction from one organ is proposed to act on that same organ, restoring its protein synthesis toward a younger pattern by binding regulatory DNA sequences. The mechanism is coherent and the human evidence for it is thin outside the group that proposed it.

  • Oral

On the goal map: Brain & pineal (Organ-specific bioregulation)

Research on Visoluten4 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Evidence on file: Theoretical — Khavinson-school work, largely Russian-language and rarely replicated outside it.

Human clinical evidence

  • No randomized human trials — a research compound with no commercial route to funding one, so the correlative and theoretical tiers are the evidence base rather than a consolation prize.

    No completed human trial

Correlative data

  • The Khavinson group reported improvements in organ-specific markers across a long series of studies from the 1980s onward. These are overwhelmingly small, single-arm, and published in Russian-language journals; independent replication outside that school is close to absent.

How the mechanism reads

  • The proposal is tissue specificity: a short peptide fraction taken from one organ acts preferentially on that same organ, binding regulatory DNA sequences and shifting protein synthesis toward a younger pattern.

    Mechanistic
  • Oral delivery is the open question, not the mechanism. Peptides are poorly absorbed intact from the gut. Whether enough survives to reach the target tissue has not been shown in a way anyone outside the manufacturer can check.

    Mechanistic

Sources

  • Suetov AA. Retinoprotective effects of Retinalamin studied in an experimental model of photochemical damage to rabbit retinas. Vestnik Oftalmologii 2021 [Russian] · PMID 34726859
  • Avetisov SE. Evaluation of therapeutic sensitivity of retinal ganglion cells to targeted peptide bioregulator in culture. Vestnik Oftalmologii 2019 [Russian] · PMID 30830079
  • Malakhova AI. Objective structural and functional monitoring of polypeptide retinal neuroprotective therapy in diabetic retinopathy. Vestnik Oftalmologii 2024 [Russian] · PMID 39569781
  • Makashova NV, Vasil'eva AE, Morozova NE, Ronzina IA. Application of Retinalamin for the treatment of glaucomatous optic neuropathy. Vestnik Oftalmologii 2014 [Russian] · PMID 25306728
  • Khvatova AV, Khlebnikova OV, Meshkova GI, Tarasenkov AO, Shchuvatova EL, Stromova OV. Polypeptide bioregulators in the treatment of different-type abiotrophy of the retina. Vestnik Oftalmologii 2005 [Russian] · PMID 15881150
  • Khavinson VKh. Inductive activity of retinal peptides. Bulletin of Experimental Biology and Medicine 2002 · PMID 12802458
  • Khavinson VKh. Effects of peptides on proliferative activity of retinal and pigmented epithelial cells. Bulletin of Experimental Biology and Medicine 2003 · PMID 12937684

Visoluten safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Animal protein allergy: it is a retinal peptide fraction.
  • Any untreated eye disease: a tissue extract is not a diagnosis or a treatment for glaucoma or macular disease.
  • Pregnancy: an animal retinal extract is an undefined mixture with no gestation data.
  • Under 18: retinal peptide signaling during eye growth is untested.

What’s expected

  • Likely nothing felt; evidence is largely from the school that proposed it.
  • Mild digestive upset.
  • Any benefit would be slow.

Watch for

  • Sudden vision loss or flashes.
  • Eye pain with redness.
  • Hives while using Visoluten.
  • Blurred central vision.

Labs that tell you it’s working

  • HbA1c (Hemoglobin A1c)
  • Vitamin A
  • Lipid Panel
  • hs-CRP (C-Reactive Protein, High Sensitivity)

Visoluten (A-11) is an oral retina peptide fraction; the class claim is organ-specific action, and eye-health drivers are the measurable labs.

Bloodwork to runHow you would know it is working: 7 tests in one order, code CAMERON

Visoluten FAQ4 common questions

Is Visoluten approved for human use?
No. Visoluten is a research compound. No completed randomized human trial has given it yet.
What is Visoluten researched for?
Retinal ageing and visual function; the eye-specific bioregulator.
Which labs show whether it's doing anything?
HbA1c; Vitamin A; Lipid Panel; hs-CRP: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for Visoluten: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what Visoluten is. Skool covers how it is run.

Free on this page

What Visoluten is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What Visoluten is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool